Clinical Trials Browser

Neoplasm Metastasis × Rituximab × Dermatologic × Clear all

NCT01032122 2013-04-25

Rituximab in Metastatic Melanoma

Phase 1 Terminated

Melanoma, Neoplasm Metastasis